Skip to main content
. 2022 Jul 5;13:848586. doi: 10.3389/fimmu.2022.848586

Figure 4.

Figure 4

Distribution of the cellular immune response to SARS-CoV-2 by IFN-γELISpot, CoVITEST and antibodies against the Receptor Binding Domain (RBD) of the spike glycoprotein of SARS-CoV-2 (IgG, IgA or IgM) by Luminex in 51 COVID-19 patients.